Building on previous events held in Washington, D.C. (2015) and Hong Kong (2018), this Summit will continue the important dialogue around human genome editing. It will facilitate a global discussion on somatic and germline genome editing, including developments in clinical trials and genome editing tools such as CRISPR/Cas9. It will also address the recent report from the International Commission on the Clinical use of Heritable Human Genome Editing and the WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing report.
The three-day Summit is being organised by the Royal Society, the UK Academy of Medical Sciences, the US National Academies of Sciences and Medicine and The World Academy of Sciences. The Academies’ Presidents have issued a statement on the Third International Summit on Human Genome Editing (PDF).
Details of the Summit’s Planning Committee, chaired by Professor Robin Lovell-Badge FRS FMedSci, can be found here.
Further information and details on how to access the Summit will be released closer to the time.